论文信息 - Safety and Clinical Activity of Temsirolimus in Combination with Rituximab and DHAP in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Results of the Part I Cohort of the STORM Trial - 字舞流文

Safety and Clinical Activity of Temsirolimus in Combination with Rituximab and DHAP in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Results of the Part I Cohort of the STORM Trial

C. Buske | A. Ho | M. Dreyling | G. Hess | M. Witzens‐Harig | R. Marks | A. Viardot | U. Keller | J. Meissner | A. Crombé | E. Hoenig